565 related articles for article (PubMed ID: 2938728)
1. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
2. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
Schein PS; Green D; Dean SW; McPherson E
Cancer Res; 1987 Feb; 47(3):696-9. PubMed ID: 3802075
[TBL] [Abstract][Full Text] [Related]
3. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of tetraacetylglucosamine mustard.
Wampler GL; Nassiri SK; Hsiao YY; Bardos TJ; Regelson W
Cancer Res; 1975 Aug; 35(8):1903-6. PubMed ID: 1149014
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
6. 6-bis-(2-chloroethyl)amino-6-deoxy-D-galactopyranose hydrochloride: synthesis, chemical characterization, murine P388 antitumor activity, and bone marrow toxicity.
Schein PS; Green D; Hammer CF; McPherson E; Talebian A
J Pharm Sci; 1989 Nov; 78(11):918-21. PubMed ID: 2621574
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Heal JM; Fox PA; Doukas D; Schein PS
Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
Nagourney RA; Fox P; Schein PS
Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
[TBL] [Abstract][Full Text] [Related]
9. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
10. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
Anderson T; McMenamin MG; Schein PS
Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.
Lazarus P; Dufour M; Isabel G; Panasci LC
Cancer Chemother Pharmacol; 1986; 16(2):148-52. PubMed ID: 3948300
[TBL] [Abstract][Full Text] [Related]
12. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
14. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
15. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
Goldenberg GJ
Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex.
Teicher BA; Abrams MJ; Rosbe KW; Herman TS
Cancer Res; 1990 Nov; 50(21):6971-5. PubMed ID: 2208163
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
19. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and cytogenetic effects of esteric (ASE) and amidic (ASA) steroidal derivative of p-bis (2-chloroethyl) amino phenylacetic acid (CAPA). A comparative study.
Nikolaropoulos SS; Arsenou ES; Papageorgiou A; Mourelatos D
Anticancer Res; 1997; 17(6D):4525-9. PubMed ID: 9494562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]